Cargando…

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) has become a common chronic liver disease in the world. Simple steatosis (SS) is the early phase of NAFLD. However, the molecular mechanisms underlying the development of steatosis have not yet been fully elucidated. METHODS: Two public...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xu, Tang, Yi, Chen, Shen, Ling, Wenhua, Wang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562889/ https://www.ncbi.nlm.nih.gov/pubmed/34524971 http://dx.doi.org/10.1530/EC-21-0353

Ejemplares similares

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses
por: Li, Gerui, et al.
Publicado: (2023)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

IGFBP6 Is Downregulated in Unstable Carotid Atherosclerotic Plaques According to an Integrated Bioinformatics Analysis and Experimental Verification
por: Liu, Yandong, et al.
Publicado: (2020)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
por: Shih, Ping-Hsiao, et al.
Publicado: (2021)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
por: Miyata, Masaaki, et al.
Publicado: (2020)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022)

AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD
por: Wen, Ling, et al.
Publicado: (2022)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2022)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD
por: Ashworth, William B., et al.
Publicado: (2016)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

Correction: The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2023)

Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD
por: Petäjä, Elina M., et al.
Publicado: (2016)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Matsui, Masahiro, et al.
Publicado: (2021)

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
por: Beyer, Cayden, et al.
Publicado: (2021)

HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
por: Ding, Jiexia, et al.
Publicado: (2022)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis
por: Yetukuri, Laxman, et al.
Publicado: (2007)

Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis
por: Guo, Xing-Ya, et al.
Publicado: (2017)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD
por: Wang, Cheng-Hui, et al.
Publicado: (2021)

Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology
por: Luo, Xiaomin, et al.
Publicado: (2022)

Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice
por: Wang, Wei, et al.
Publicado: (2020)

IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker
por: Chen, Qiuyan, et al.
Publicado: (2016)

Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
por: Zhu, Wei, et al.
Publicado: (2014)

Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and (1)H-MR Spectroscopy
por: Karlas, Thomas, et al.
Publicado: (2014)

Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery
por: Toyoda, Yu, et al.
Publicado: (2019)

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
por: Serrano-Maciá, Marina, et al.
Publicado: (2021)

Intrahepatic fatty acids composition as a biomarker of NAFLD progression from steatosis to NASH by using (1)H-MRS
por: Xavier, Aline, et al.
Publicado: (2019)

Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD
por: Sapmaz, Ferdane, et al.
Publicado: (2016)

Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer
por: Liu, Qi, et al.
Publicado: (2021)

High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC
por: Shen, Tingting, et al.
Publicado: (2020)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma
por: Luo, Xiao-Ye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_clguc0h6t03m160knegm0bgc2o